Skip to main navigation Skip to search Skip to main content

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

  • Cameron Chalker
  • , Jenna M. Voutsinas
  • , Qian Vicky Wu
  • , Rafael Santana-Davila
  • , Victoria Hwang
  • , Christina S. Baik
  • , Sylvia Lee
  • , Brittany Barber
  • , Neal D. Futran
  • , Jeffrey J. Houlton
  • , George E. Laramore
  • , Jay Justin Liao
  • , Upendra Parvathaneni
  • , Renato G. Martins
  • , Keith D. Eaton
  • , Cristina P. Rodriguez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience